Not All Compounded Tirzepatide is Equal: The Importance of Quality in Weight Management Tirzepatide, a dual GLP-1/GIP receptor agonist (brand names Mounjaro or Zepbound), is FDA-approved for type 2 diabetes and chronic weight management. However, compounded versions vary significantly in quality, purity, and formulation. Not all compounded Tirzepatide is equal, as differences in active ingredient…
Read more
Not All Compounded Tirzepatide is Equal: Quality Matters for Results and Safety
